Trial Profile
Special Drug Use Surveillance of Irribow Tablets and Irribow OD Tablets in Female Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Ramosetron (Primary)
- Indications Irritable bowel syndrome
- Focus Adverse reactions
- Sponsors Astellas Pharma
- 12 Jun 2018 Status changed from active, no longer recruiting to completed.
- 24 Apr 2017 Status changed from recruiting to active, no longer recruiting.
- 27 Nov 2015 New trial record